Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients.
Saved in:
| Title: | Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients. |
|---|---|
| Authors: | Sukari A; Department of Oncology, Barbara Ann Karmanos Comprehensive Cancer Institute, Detroit, Michigan., Nagasaka M; Department of Oncology, Barbara Ann Karmanos Comprehensive Cancer Institute, Detroit, Michigan.; Department of Advanced Medical Innovation, St. Marianna University Graduate School of Medicine, Kawasaki, Japan., Diab M; Department of Oncology, Barbara Ann Karmanos Comprehensive Cancer Institute, Detroit, Michigan., Al Sibai K; Alfaisal University College of Medicine, Riyadh, Saudi Arabia., Atassi B; Chicago Medical School Internal Medicine, Hematology and Clinical Oncology, The Cancer Center at Little Company of Mary Hospital, Evergreen Park, Illinois., Elayoubi JA; Department of Internal Medicine, Beaumont Dearborn, Dearborn, Michigan., Kim S; Department of Oncology, Barbara Ann Karmanos Comprehensive Cancer Institute, Detroit, Michigan., Küçük Ö; Department of Hematology-Oncology and Urology, Winship Cancer Institute of Emory University, Atlanta, Georgia. |
| Source: | Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery [Clin Otolaryngol] 2019 Jul; Vol. 44 (4), pp. 639-643. Date of Electronic Publication: 2019 Apr 01. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101247023 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1749-4486 (Electronic) Linking ISSN: 17494478 NLM ISO Abbreviation: Clin Otolaryngol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
